Next |
home / stock / armp / armp message board
Subject | By | Source | When |
---|---|---|---|
Interesting article. | gumshoe22 | investorshub | 07/08/2022 4:18:38 PM |
Here's an interesting article on how a bacteriophage | lesgetrich | investorshub | 01/15/2022 4:20:37 PM |
ARMATA MORE GOOD NEWS FDA Clearance | gator16 | investorshub | 11/18/2021 2:28:35 PM |
There was a PR last Friday... | lesgetrich | investorshub | 11/03/2021 3:50:03 PM |
Do I detect a pulse? | gumshoe22 | investorshub | 11/03/2021 3:31:52 PM |
But to go from around 30k avg volume | gumshoe22 | investorshub | 01/29/2021 2:43:34 PM |
Looks like people are finally noticing Armata. It's | lesgetrich | investorshub | 01/29/2021 2:31:42 PM |
Should be an interesting day tomorrow. :) | gumshoe22 | investorshub | 01/28/2021 8:24:35 PM |
Trading halted, up $2.65. What's going on? | gumshoe22 | investorshub | 01/28/2021 8:05:50 PM |
New PR is out... | lesgetrich | investorshub | 08/14/2020 1:13:16 PM |
Here's the PR... | lesgetrich | investorshub | 06/17/2020 3:20:08 PM |
Armata Pharmaceuticals Announces $15 Million Award from the | gumshoe22 | investorshub | 06/17/2020 1:35:01 PM |
Reason for the high pps is that there | lesgetrich | investorshub | 05/26/2020 6:33:38 PM |
still tracking this one, but own no shares.. | timberwolf7 | investorshub | 05/26/2020 1:11:19 PM |
For what it's worth, financials (10-Q) are due | lesgetrich | investorshub | 05/04/2020 12:22:37 PM |
Just dropping in to see whats been going on. | timberwolf7 | investorshub | 05/03/2020 8:37:58 AM |
Armata Pharmaceuticals Files for $100 Million Mixed Shelf | gumshoe22 | investorshub | 04/03/2020 1:42:42 PM |
Well, everything is done. Let's see how | gumshoe22 | investorshub | 03/30/2020 4:32:09 PM |
Here's more on the Innoviva agreement. Armata will | lesgetrich | investorshub | 03/19/2020 12:28:27 PM |
Nice Find! Here's more... | lesgetrich | investorshub | 03/19/2020 12:08:23 PM |
News, Short Squeeze, Breakout and More Instantly...
Armata Pharmaceuticals Inc. Company Name:
ARMP Stock Symbol:
NYSE Market:
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , March 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology com...
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva PR Newswire Proceeds to be used to continue to advance rigorously designed clinical trials of Armata's high purity phage-based therapeutic candidates LOS ANGELES , March 4, 20...
Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit PR Newswire LOS ANGELES , Feb. 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on...